The Korea National Institute of Health has succeeded in producing a protein detecting an antibody to COVID-19 in blood. The institute has worked on an examination method with COVID-19 patients’ blood to confirm immune reactions. The production of the protein is expected to accelerate the development
Korea Ginseng Corp (KGC) announced that “Cheong Kwan Jang Red Ginseng Extract Every Time” broke through a milestone of 200 million bags in cumulative sales –- about four bags per a Korean citizen.Cheong Kwan Jang Red Ginseng Extract Every Time is very portable and easy to have by adding only purifie
JW Holdings announced on Feb. 17 that it has obtained a patent from the U.S. Patent and Trademark Office (USPTO) for its technology to produce the world's first multiple biomarker diagnostic kit that can detect pancreatic cancer early through a simple blood test.The company has developed an inno
Hanmi Pharmaceutical announced on Jan. 30 that it sold 153 billion won worth of hypertension drugs last year, ranking first in this segment of the Korean drug market. The company's high blood pressure drug lineup consists of 15 products.The Korean hypertension drug market stood at 1,835 billion
GC Pharma is stepping up efforts to upgrade its existing products and develop innovative new drugs based on its research capabilities accumulated through the localization of blood products and vaccines.The company is carrying out phase II and III clinical trials on HepaBig-Gin (GC1102), a recombinan
Korean scientists have discovered ways to replicate pancreatic beta cells destroyed by type 1 diabetes, which is usually diagnosed in children, teens, and young adults.Type 1 diabetes is a condition in which the patient’s immune system destroys insulin-making cells in their pancreas. These are calle
South Korean researchers have successfully developed a technology to apply 3D printing to high value-added biomedical materials that can be used for artificial joints and artificial blood vessels.The National Research Foundation of Korea (NRF) announced on Oct. 28 that the research team led by Hyun
An increasing number of South Korean pharmaceutical companies are setting up R&D centers in Boston, one of the largest biotech hubs in the world, to accelerate new drug development based on more open innovation with American companies.For instance, Green Cross Corporation’s Boston office is schedule
The Korean Ministry of SMEs and Startups and the INNOBIZ Association announced on Sept. 20 that they jointly held the first Korea-Turkey SMEs Technology Matching Conference in 2019 at Marmara Hotel in Istanbul, Turkey from Sept. 17-18.At the conference, six Korean SMEs held business meetings with ap
SK Plasma, an SK Group company specializing in blood products, announced on Sep. 1 that it has signed a three-party MOU with state-owned Indonesian pharmaceutical company Bio Pharma and the Indonesian Red Cross for production of blood plasma for Indonesia and technology transfer to its Indonesian pa
Seoul Semiconductor has officially apologized for the recent radiation exposure accident."The Nuclear Safety and Security Commission is looking into the accident and has confirmed that seven workers are suspected of being exposed to radiation," Seoul Semiconductor said in a statement released on Aug
Boryung Pharmaceutical Co. announced on Aug. 19 that it has started selling its new antihypertensive combination drug Arahkor Duo, known as Dukarb in South Korea, in Mexico.Arahkor Duo is the third drug that Boryung launches in Mexico after Arahkor, known as Kanarb in South Korea, in 2014 and Diarak
JW Holdings announced on July 16 that it has won a patent in EU for its source technology for a “multi-biomarker diagnostic kit” that can detect pancreatic cancer during its early stages with a simple blood test.The company said its technology is an innovative diagnostic platform that helps detect p
Dong-A ST Co. are stepping up efforts to develop new drugs. The company has developed four new homegrown treatments and has been investing 10 percent of its sales in research and development (R&D) every year to achieve its goal to become a leading company with globally sold new medicines.The company
Hanmi Pharmaceutical announced on July 3 that its partner Janssen has returned the rights of the obesity and diabetes treatment HM12525A that the Korean pharmaceutical company has licensed out for 1 trillion won.Hanmi Pharmaceutical does not have to return a down payment of US$105 million (about 123
A technique that can easily diagnose cancer with only a small amount of plasma has been developed. Unlike antibody-based technology that diagnoses individual cancers, it can be used as a complementary technology to existing cancer diagnosis because it can diagnose various types of cancer at a time.T
Korean biotechnology startups are seeking to enter the U.S. market, the largest biopharmaceutical market in the world.The Korea Trade-Investment Promotion Agency (KOTRA) said on May 26 that 12 Korean biotechnology companies will participate in the 2019 Bio International Convention, which is a large-
Precision medical biotechnology company Macrogen has been designated by the Ministry of Food and Drug Safety (MFDS) as a clinical trial specimen analysis institution, which performs specimen analysis of blood and urine collected from clinical test subjects.Macrogen can now perform next-generation se
Domestic biopharmaceutical companies are putting more efforts into research and development (R&D) to advance into the rapidly growing immune cancer drug market.Boryung Pharmaceutical started on April 23 the operation of a new production complex in the Junggok industrial complex in South Chungcheon P
JW Holdings announced on May 9 that it has obtained a patent in China on its original technique for the world’s first multi-biomarker diagnostic kit with which pancreatic cancer can be detected early through a simple blood test.The technique is an innovative diagnostic platform allowing stage-specif